Jiangsu Lianhuan Pharmaceutical Co., Ltd. 600513.SS Stock
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Price Chart
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 600513.SS Financial and Trading Overview
Contents
- Jiangsu Lianhuan Pharmaceutical Co., Ltd. Price Chart
- Jiangsu Lianhuan Pharmaceutical Co., Ltd. 600513.SS Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Jiangsu Lianhuan Pharmaceutical Co., Ltd.
- Q&A For Jiangsu Lianhuan Pharmaceutical Co., Ltd. Stock
Jiangsu Lianhuan Pharmaceutical Co., Ltd. stock price | 8.81 CNY |
Previous Close | 9.66 CNY |
Open | 9.67 CNY |
Bid | 9.69 CNY x 0 |
Ask | 9.7 CNY x 0 |
Day's Range | 9.63 - 9.75 CNY |
52 Week Range | 8.41 - 11.47 CNY |
Volume | 2.49M CNY |
Avg. Volume | 6.02M CNY |
Market Cap | 2.78B CNY |
Beta (5Y Monthly) | 0.371594 |
PE Ratio (TTM) | 19.775509 |
EPS (TTM) | 0.47 CNY |
Forward Dividend & Yield | 0.15 (1.54%) |
Ex-Dividend Date | May 26, 2023 |
1y Target Est | N/A |
600513.SS Valuation Measures
Enterprise Value | 3.32B CNY |
Trailing P/E | 19.775509 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.3895005 |
Price/Book (mrq) | 2.142857 |
Enterprise Value/Revenue | 1.658 |
Enterprise Value/EBITDA | 13.232 |
Trading Information
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.371594 |
52-Week Change | -9.039% |
S&P500 52-Week Change | 20.43% |
52 Week High | 11.47 CNY |
52 Week Low | 8.41 CNY |
50-Day Moving Average | 10.28 CNY |
200-Day Moving Average | 10 CNY |
600513.SS Share Statistics
Avg. Volume (3 month) | 6.02M CNY |
Avg. Daily Volume (10-Days) | 2.89M CNY |
Shares Outstanding | 287.15M |
Float | 171.27M |
Short Ratio | N/A |
% Held by Insiders | 40.73% |
% Held by Institutions | 1.85% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.15 |
Trailing Annual Dividend Yield | 1.55% |
5 Year Average Dividend Yield | 107.00% |
Payout Ratio | 0.2551 |
Last Split Factor | 13:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 7.09% |
Operating Margin (ttm) | 10.34% |
Gross Margin | 52.70% |
EBITDA Margin | 12.52% |
Management Effectiveness
Return on Assets (ttm) | 4.99% |
Return on Equity (ttm) | 11.83% |
Income Statement
Revenue (ttm) | 2B CNY |
Revenue Per Share (ttm) | 6.9 CNY |
Quarterly Revenue Growth (yoy) | 11.70% |
Gross Profit (ttm) | 1.04B CNY |
EBITDA | 250.88M CNY |
Net Income Avi to Common (ttm) | 142.08M CNY |
Diluted EPS (ttm) | 0.49 |
Quarterly Earnings Growth (yoy) | 2.29% |
Balance Sheet
Total Cash (mrq) | 253.87M CNY |
Total Cash Per Share (mrq) | 0.88 CNY |
Total Debt (mrq) | 634.24M CNY |
Total Debt/Equity (mrq) | 43.75 CNY |
Current Ratio (mrq) | 1.108 |
Book Value Per Share (mrq) | 4.522 |
Cash Flow Statement
Operating Cash Flow (ttm) | 138.31M CNY |
Levered Free Cash Flow (ttm) | -55317364 CNY |
Profile of Jiangsu Lianhuan Pharmaceutical Co., Ltd.
Country | China |
State | N/A |
City | Yangzhou |
Address | No. 9, Jiankang Road |
ZIP | 225127 |
Phone | 86 514 8781 3082 |
Website | https://www.lhpharma.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 1276 |
Jiangsu Lianhuan Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals, preparations, and API products in China. The company offers clopidogrel bisulfate tablets used to prevent atherothrombotic events; azithromycin tablets for the treatment of mild to moderate infections caused by susceptible strains of designated microorganisms; milrinone injection for short-term intravenous therapy in patients with acute compensated heart failure; and dapoxetine hydrochloride tablets for the treatment of premature ejaculation in men, as well as epulet, ebastine, felodipine, and terfenadine tablets, drotaverine hydrochloride injection, and danazol suppository. It also offers preparation products, which covers urinary system, antihistamines, cardiovascular drugs, steroid hormones, and antibiotics. In addition, the company engages in the wholesale of chemical raw materials and pharmaceuticals, as well as provides technological transfers and technical consultation services. It exports its products to Southeast Asia, North America, South America, Europe, New Zealand, Australia, and other countries. The company was founded in 1999 and is headquartered in Yangzhou, China.
Q&A For Jiangsu Lianhuan Pharmaceutical Co., Ltd. Stock
What is a current 600513.SS stock price?
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 600513.SS stock price today per share is 8.81 CNY.
How to purchase Jiangsu Lianhuan Pharmaceutical Co., Ltd. stock?
You can buy 600513.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Jiangsu Lianhuan Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Jiangsu Lianhuan Pharmaceutical Co., Ltd. is 600513.SS.
Which industry does the Jiangsu Lianhuan Pharmaceutical Co., Ltd. company belong to?
The Jiangsu Lianhuan Pharmaceutical Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Jiangsu Lianhuan Pharmaceutical Co., Ltd. have in circulation?
The max supply of Jiangsu Lianhuan Pharmaceutical Co., Ltd. shares is 285.46M.
What is Jiangsu Lianhuan Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Jiangsu Lianhuan Pharmaceutical Co., Ltd. PE Ratio is 18.74468200 now.
What was Jiangsu Lianhuan Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Jiangsu Lianhuan Pharmaceutical Co., Ltd. EPS is 0.47 CNY over the trailing 12 months.
Which sector does the Jiangsu Lianhuan Pharmaceutical Co., Ltd. company belong to?
The Jiangsu Lianhuan Pharmaceutical Co., Ltd. sector is Healthcare.